KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash & Equivalents (2016 - 2025)

LifeMD's Cash & Equivalents history spans 14 years, with the latest figure at $36.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 12.66% year-over-year to $36.8 million; the TTM value through Dec 2025 reached $36.8 million, up 12.66%, while the annual FY2025 figure was $36.8 million, 12.66% up from the prior year.
  • Cash & Equivalents reached $36.8 million in Q4 2025 per LFMD's latest filing, up from $23.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $41.3 million in Q4 2021 to a low of $4.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $23.6 million, with a median of $24.4 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: soared 5080.48% in 2021, then tumbled 90.42% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $41.3 million in 2021, then crashed by 90.42% to $4.0 million in 2022, then skyrocketed by 737.26% to $33.1 million in 2023, then dropped by 1.49% to $32.7 million in 2024, then grew by 12.66% to $36.8 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Cash & Equivalents are $36.8 million (Q4 2025), $23.8 million (Q3 2025), and $36.2 million (Q2 2025).